100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Xorcetam 250mg Tablet
Trireme Life Sciences Pvt. Ltd.
₹150
Our Recommendation
Levetafine 250mg Tablet 10s
4,464+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Epilepsy/Seizures
Customers also bought
More About Xorcetam 250mg Tablet
Benefits
In Treatment of Epilepsy/Seizures Xorcetam 250mg Tablet belongs to a group of medicines called anticonvulsants (or anti-epileptics). It works by slowing down electrical signals in the brain which cause seizures (fits). This medicine can be used to control various types of seizures?myoclonic, partial-onset, and primary generalized tonic-clonic (or grand mal). It can also help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. The medicine can allow you to do some activities that you would otherwise be forbidden or scared to do (such as swimming and driving). It can take a few weeks for this medicine to work (because the dose has to be increased slowly) and during this time you may still have seizures. You should continue taking it even if you feel well and are not having any seizures. Missing doses may trigger a seizure. Do not stop using this medicine until your doctor advises you.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Xorcetam 250mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Xorcetam 250mg Tablet is an antiepileptic medication. It works by attaching to specific sites (SV2A) on the surfaces of nerve cells. This suppresses the abnormal activity of the nerve cells in the brain and prevents the spread of electrical signals that cause seizures.
Unsafe: Avoid consuming alcohol with Xorcetam 250mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Xorcetam 250mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Xorcetam 250mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Monitor the baby for sleepiness and adequate weight gain.
Not Safe: Xorcetam 250mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Xorcetam 250mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Xorcetam 250mg Tablet may be needed. Doctor consultation is advised.
Safe when prescribed by an expert: Xorcetam 250mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Xorcetam 250mg Tablet may not be needed in these patients. Doctor consultation is advised. However, a lower dose may be advised in patients with severe liver disease.
What if I forget to take it?
If a dose of Xorcetam 250mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Kasba Area,Kolkata - 700039, West Bengal, India
References
Stahl SM, editor. Levetiracetam. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 333-36
McNamara JO. Pharmacotherapy of the Epilepsies. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 600
Porters RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 411
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 789
Levetiracetam (16 Jul. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Drugs and Lactation Database (LactMed®) (08 Jul. 2023)
Levetiracetam (08 Jul. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Health Articles
